Detalhe da pesquisa
1.
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Neurol Sci
; 45(2): 379-389, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159147
2.
Severe febrile neutropenia associated with satralizumab in an Argentinian neuromyelitis optica spectrum disorder patient.
Mult Scler
; 29(1): 150-153, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437566
3.
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Mult Scler
; 29(10): 1240-1249, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491849
4.
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
J Neurol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630312
5.
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
J Neurol Sci
; 461: 123052, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797140
6.
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Mult Scler J Exp Transl Clin
; 9(1): 20552173231154712, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36846108
7.
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Mult Scler Relat Disord
; 79: 104935, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634468
8.
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from Argentina.
Mult Scler Relat Disord
; 58: 103483, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032883